[Clinical outcome of treatment with infliximab in Crohn's disease: a single-center experience].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

Volumn 61, Issue 5, 2013, Pages 270-278

  Kim, Yeon Ju ^a   Kim, Jung Wook ^b   Lee, Chang Kyun ^b   Park, Hyun Jin ^b   Shim, Jae Jun ^b   Jang, Jae Young ^b   Dong, Suk Ho ^b   Kim, Hyo Jong ^b   Kim, Byung Ho ^b   Chang, Young Woon ^b  

^a Kyung Hee University Hospital   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY;

ADULT; CROHN DISEASE; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; MALE; RETROSPECTIVE STUDY; RISK; STATISTICAL MODEL; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; HERPES ZOSTER; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84891458406     PISSN: 15989992     EISSN: None     Source Type: Journal    
DOI: 10.4166/kjg.2013.61.5.270     Document Type: Article

References (0)